Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antibiotic   Vancomycin hydrochloride  
Injection
Eye-drops Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Amplobac Brazil
Anco L IV Turkey
Celovan Brazil, India, Peru, Venezuela
Dhacocin Malaysia
Edicin Poland, Romania, Slovenia, Turkey
Estafimac Mexico
Estavam Mexico
Imvaco Chile
Kovan Chile
Rivervan Argentina
Tancofeto Colombia, Malaysia
Vacsol Mexico
Valcidem Mexico
Vamysin Belgium, Luxembourg
Vanaurus Colombia, Ecuador
Vanbiotic Colombia, Ecuador
Vancam Mexico
Vancobact Egypt
Vancobiotic Peru
Vancocare India
Vancocin Australia, Austria, Canada, Great Britain, Hungary, India, Ireland, Luxembourg, Netherlands, Poland, Saudi Arabia, Sweden, Switzerland, United Arab Emirates, United States of America
Vancocina Brazil, Italy
Vancofar Peru
Vancogen India
Vancoled India, United Arab Emirates
Vancolon Egypt, Saudi Arabia, United Arab Emirates
Vancomate India
Vancomax Argentina, Ecuador, Iran, Peru
Vancomicina Argentina, Chile, Colombia, Ecuador, Italy, Mexico, Portugal, Romania, Spain, Tunisia
Vancomix Egypt
Vancomycin Australia, Austria, Canada, Denmark, Egypt, Finland, Germany, Great Britain, Greece, Hungary, Iceland, Ireland, New Zealand, Norway, Saudi Arabia, Sweden, United Arab Emirates, United States of America
Vancomycine Belgium, Egypt, France, Luxembourg, Morocco, Netherlands, Switzerland
Vanconat India
Vanconor Peru
Vancorin India, Malaysia, Turkey
Vancosan Germany, Greece
Vancoser India
Vancotek Turkey
Vancotex Italy
Vancox Mexico
Vankomisin Turkey
Vanlid India, Malaysia, Venezuela
Varedet Argentina, Colombia, Ecuador, Peru
Yestafhal Mexico
Zengac Italy
Stability in solutions   Injection   Stability in solutions : Vancomycin hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 2 mg/ml 2-8°C Protect from light
7 Day
702
Level of evidence D
Glass NaCl 0,9% or Glucose 5% 2 mg/ml 25°C Protect from light
48 Hour
702
Level of evidence D
Glass NaCl 0,9% or Glucose 5% 5 mg/ml -10°C Protect from light
63 Day
430
Level of evidence B
Glass NaCl 0,9% or Glucose 5% 5 mg/ml 24°C Not specified
17 Day
430
Level of evidence B
Glass NaCl 0,9% or Glucose 5% 5 mg/ml 5°C Protect from light
63 Day
430
Level of evidence B
Glass Sodium chloride 0,9% 0,025 mg/ml 4°C Protect from light
63 Day
1414
Biological analysis
Glass Sodium chloride 0,9% 10 mg/ml -20°C Protect from light
90 Day
3120
Level of evidence A+
Glass Sodium chloride 0,9% 10 mg/ml 25°C Not specified
48 Hour
3120
Level of evidence A+
Glass Sodium chloride 0,9% 10 mg/ml 4°C Not specified
8 Day
3120
Level of evidence A+
Glass Glucose 5% 25 mg/ml -20°C Not specified
90 Day
1871
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 2 mg/ml 2-8°C Protect from light
7 Day
702
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 2 mg/ml 25°C Protect from light
48 Hour
702
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 mg/ml 22°C Light
48 Hour
1671
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 mg/ml 24°C Not specified
17 Day
430
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 mg/ml 4°C Protect from light
7 Day
1671
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 4 & 5 mg/ml 23°C Not specified
24 Day
694
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 4 & 5 mg/ml 4°C Protect from light
30 Day
694
Level of evidence B
Polyvinyl chloride Glucose 5% 0,5 & 1 mg/ml 4°C Protect from light
58 Day
931
Level of evidence A
Polyvinyl chloride Glucose 5% 20 & 40 mg/ml 25°C Not specified
96 Hour
654
Level of evidence B
Polyvinyl chloride Glucose 5% 20 & 40 mg/ml 5°C Not specified
30 Day
654
Level of evidence B
Polyvinyl chloride Glucose 5% 4 & 5 mg/ml 23°C Not specified
17 Day
694
Level of evidence B
Polyvinyl chloride Glucose 5% 4 & 5 mg/ml 4°C Protect from light
24 Day
694
Level of evidence B
Polyvinyl chloride Dianéal® PD1 1.36% glucose (Baxter) 0,025 mg/ml 20°C
28 Day
2370
Level of evidence B
Polyvinyl chloride Dianéal® PD1 1.36% glucose (Baxter) 0,025 mg/ml 37°C
7 Day
2370
Level of evidence B
Polyvinyl chloride Dianéal® PD1 1.36% glucose (Baxter) 0,025 mg/ml 4°C Not specified
28 Day
2370
Level of evidence B
Polyvinyl chloride Dianéal® PD1 3.86% glucose (Baxter) 0,025 mg/ml 20°C Light
28 Day
2370
Level of evidence B
Polyvinyl chloride Dianéal® PD1 3.86% glucose (Baxter) 0,025 mg/ml 37°C Light
5 Day
2370
Level of evidence B
Polyvinyl chloride Dianéal® PD1 3.86% glucose (Baxter) 0,025 mg/ml 4°C Not specified
28 Day
2370
Level of evidence B
Polyvinyl chloride Extraneal® (Baxter) 0.94 mg/ml 24°C Protect from light
7 Day
2147
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 0.94 mg/ml 37°C Protect from light
24 Hour
2147
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 0.94 mg/ml 5°C Protect from light
7 Day
2147
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 1 mg/ml 25°C Protect from light
14 Day
3888
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 1 mg/ml 37°C Protect from light
4 Day
3888
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 1 mg/ml 4°C Protect from light
14 Day
3888
Level of evidence D
Polyethylene Water for Injection 10 mg/ml 25°C Protect from light
29 Day
913
Level of evidence B
Polyethylene Water for Injection 10 mg/ml 4°C Protect from light
84 Day
913
Level of evidence B
Polyethylene NaCl 0,9% or Glucose 5% 10 mg/ml 25°C Protect from light
33 Day
913
Level of evidence B
Polyethylene NaCl 0,9% or Glucose 5% 10 mg/ml 4°C Protect from light
84 Day
913
Level of evidence B
Polyethylene Glucose 5% 5 mg/ml -20°C Protect from light
105 Day
2034
Level of evidence C
Polyethylene Glucose 5% 5 mg/ml 4°C Protect from light
56 Day
2034
Level of evidence C
Polyolefine NaCl 0,9% or Glucose 5% 2 mg/ml 2-8°C Protect from light
7 Day
702
Level of evidence D
Polyolefine NaCl 0,9% or Glucose 5% 2 mg/ml 25°C Protect from light
48 Hour
702
Level of evidence D
Ethylene vinyl acetate Sodium chloride 0,9% 10 mg/ml 23°C Protect from light
7 Day
1614
Level of evidence A+
Ethylene vinyl acetate Sodium chloride 0,9% 10 mg/ml 4°C Protect from light
30 Day
1614
Level of evidence A+
Polypropylen Syringe Water for Injection 10 mg/ml 25°C Protect from light
47 Day
913
Level of evidence B
Polypropylen Syringe Water for Injection 10 mg/ml 4°C Protect from light
84 Day
913
Level of evidence B
Polypropylen Syringe Water for Injection 40 mg/ml 20-25°C Light
24 Hour
4007
Level of evidence D
Polypropylen Syringe NaCl 0,9% or Glucose 5% 10 mg/ml 4°C Protect from light
84 Day
913
Level of evidence B
Polypropylen Syringe NaCl 0,9% or Glucose 5% 41.67 mg/ml 18-25°C Light
48 Hour
4089
Level of evidence A+
Polypropylen Syringe NaCl 0,9% or Glucose 5% 5 mg/ml 25°C Not specified
48 Hour
2173
Level of evidence B
Polypropylen Syringe NaCl 0,9% or Glucose 5% 5 mg/ml 4°C Not specified
180 Day
2173
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 0,025 mg/ml 4°C Protect from light
14 Day
895
Biological analysis
Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml -20°C Protect from light
168 Day
2530
Level of evidence C
Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml 25°C Protect from light
62 Day
913
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml 4°C Protect from light
98 Day
2530
Level of evidence C
Polypropylen Syringe Sodium chloride 0,9% 25 mg/ml 23-27°C Light
24 Hour
4373
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 40 mg/ml 20-25°C Light
24 Hour
4007
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 40 mg/ml 23-27°C Light
24 Hour
4373
Level of evidence A+
Polypropylen Syringe Glucose 5% 10 mg/ml 25°C Protect from light
55 Day
913
Level of evidence B
Polypropylen Syringe Glucose 5% 5 mg/ml 4°C Protect from light
24 Hour
428
Level of evidence D
Polypropylen Syringe Glucose 5% 62,5 mg/ml 20-25°C Light
48 Hour
4348
Level of evidence B+
Polypropylen Syringe Glucose 5% 62,5 >> 83,3 mg/ml 20-25°C Light
48 Hour
4634
Level of evidence C+
Polypropylen Syringe Glucose 5% 83,3 mg/ml 20-25°C Light
48 Hour
4348
Level of evidence B+
Polypropylen Syringe Glucose 10% 5 mg/ml 4°C Protect from light
24 Hour
428
Level of evidence D
Polypropylen Syringe Glucose 15% 5 mg/ml 4°C Protect from light
24 Hour
428
Level of evidence D
Polypropylen Syringe Glucose 20% 5 mg/ml 4°C Protect from light
24 Hour
428
Level of evidence D
Polypropylen Syringe Glucose 25% 5 mg/ml 4°C Protect from light
24 Hour
428
Level of evidence D
Polypropylen Syringe Glucose 30% 5 mg/ml 4°C Protect from light
24 Hour
428
Level of evidence D
Polyisoprene elastomer NaCl 0,9% or Glucose 5% 10 & 20 mg/ml 25°C Not specified
24 Hour
604
Manufacturer's stability data
Polyisoprene elastomer NaCl 0,9% or Glucose 5% 10 & 20 mg/ml 4°C Protect from light
10 Day
604
Manufacturer's stability data
Polyisoprene elastomer NaCl 0,9% or Glucose 5% 37,5 mg/ml 37°C Protect from light
48 Hour
4634
Level of evidence C+
  Mentions Légales